These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31036935)

  • 1. Gut microbiota and butyrate level changes associated with the long-term administration of proton pump inhibitors to old rats.
    Lee SM; Kim N; Nam RH; Park JH; Choi SI; Park YT; Kim YR; Seok YJ; Shin CM; Lee DH
    Sci Rep; 2019 Apr; 9(1):6626. PubMed ID: 31036935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Long-Term Proton Pump Inhibitor Therapy on Gut Microbiota in F344 Rats: Pilot Study.
    Shin CM; Kim N; Kim YS; Nam RH; Park JH; Lee DH; Seok YJ; Kim YR; Kim JH; Kim JM; Kim JS; Jung HC
    Gut Liver; 2016 Nov; 10(6):896-901. PubMed ID: 27458177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of the effects of proton pump inhibitors on the human gut microbiota.
    Zhang J; Zhang C; Zhang Q; Yu L; Chen W; Xue Y; Zhai Q
    BMC Microbiol; 2023 Jun; 23(1):171. PubMed ID: 37337143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the gut microbiome between long-term users and non-users of proton pump inhibitors.
    Clooney AG; Bernstein CN; Leslie WD; Vagianos K; Sargent M; Laserna-Mendieta EJ; Claesson MJ; Targownik LE
    Aliment Pharmacol Ther; 2016 May; 43(9):974-84. PubMed ID: 26923470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease.
    Shi YC; Cai ST; Tian YP; Zhao HJ; Zhang YB; Chen J; Ren RR; Luo X; Peng LH; Sun G; Yang YS
    Genomics Proteomics Bioinformatics; 2019 Feb; 17(1):52-63. PubMed ID: 31028880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of proton pump inhibitor or rebamipide use on gut microbiota of rheumatoid arthritis patients.
    Kim JW; Jeong Y; Park SJ; Jin H; Lee J; Ju JH; Ji GE; Park SH
    Rheumatology (Oxford); 2021 Feb; 60(2):708-716. PubMed ID: 32789440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients.
    Paroni Sterbini F; Palladini A; Masucci L; Cannistraci CV; Pastorino R; Ianiro G; Bugli F; Martini C; Ricciardi W; Gasbarrini A; Sanguinetti M; Cammarota G; Posteraro B
    Appl Environ Microbiol; 2016 Nov; 82(22):6633-6644. PubMed ID: 27590821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors alter gut microbiota by promoting oral microbiota translocation: a prospective interventional study.
    Xiao X; Zhang X; Wang J; Liu Y; Yan H; Xing X; Yang J
    Gut; 2024 Jun; 73(7):1098-1109. PubMed ID: 38267200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiota Composition Before and After Use of Proton Pump Inhibitors.
    Hojo M; Asahara T; Nagahara A; Takeda T; Matsumoto K; Ueyama H; Matsumoto K; Asaoka D; Takahashi T; Nomoto K; Yamashiro Y; Watanabe S
    Dig Dis Sci; 2018 Nov; 63(11):2940-2949. PubMed ID: 29796911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher Risk of Stroke Is Correlated With Increased Opportunistic Pathogen Load and Reduced Levels of Butyrate-Producing Bacteria in the Gut.
    Zeng X; Gao X; Peng Y; Wu Q; Zhu J; Tan C; Xia G; You C; Xu R; Pan S; Zhou H; He Y; Yin J
    Front Cell Infect Microbiol; 2019; 9():4. PubMed ID: 30778376
    [No Abstract]   [Full Text] [Related]  

  • 11. Proton pump inhibitors affect the gut microbiome.
    Imhann F; Bonder MJ; Vich Vila A; Fu J; Mujagic Z; Vork L; Tigchelaar EF; Jankipersadsing SA; Cenit MC; Harmsen HJ; Dijkstra G; Franke L; Xavier RJ; Jonkers D; Wijmenga C; Weersma RK; Zhernakova A
    Gut; 2016 May; 65(5):740-8. PubMed ID: 26657899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota Characteristics in Children After the Use of Proton Pump Inhibitors.
    Simakachorn L; Tanpowpong P; Chanprasertyothin S; Thongpradit S; Treepongkaruna S
    Turk J Gastroenterol; 2021 Jan; 32(1):70-75. PubMed ID: 33893768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors alter the composition of the gut microbiota.
    Jackson MA; Goodrich JK; Maxan ME; Freedberg DE; Abrams JA; Poole AC; Sutter JL; Welter D; Ley RE; Bell JT; Spector TD; Steves CJ
    Gut; 2016 May; 65(5):749-56. PubMed ID: 26719299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of proton pump inhibitors on microbiota in chronic liver disease patients.
    Yamamoto K; Ishigami M; Honda T; Takeyama T; Ito T; Ishizu Y; Kuzuya T; Hayashi K; Goto H; Hirooka Y
    Hepatol Int; 2019 Mar; 13(2):234-244. PubMed ID: 30737678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review: the effects of proton pump inhibitors on the microbiome of the digestive tract-evidence from next-generation sequencing studies.
    Macke L; Schulz C; Koletzko L; Malfertheiner P
    Aliment Pharmacol Ther; 2020 Mar; 51(5):505-526. PubMed ID: 31990420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoliquiritigenin decreases the incidence of colitis-associated colorectal cancer by modulating the intestinal microbiota.
    Wu M; Wu Y; Deng B; Li J; Cao H; Qu Y; Qian X; Zhong G
    Oncotarget; 2016 Dec; 7(51):85318-85331. PubMed ID: 27863401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Proton Pump Inhibitor Administration Caused Physiological and Microbiota Changes in Rats.
    Yang YSH; Chang HW; Lin IH; Chien LN; Wu MJ; Liu YR; Chu PG; Xie G; Dong F; Jia W; Chang VHS; Yen Y
    Sci Rep; 2020 Jan; 10(1):866. PubMed ID: 31964941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitors induce changes in the gut microbiome composition of systemic lupus erythematosus patients.
    Li XB; Chu XJ; Cao NW; Wang H; Fang XY; Fan YG; Li BZ; Ye DQ
    BMC Microbiol; 2022 Apr; 22(1):117. PubMed ID: 35477382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of Enterogermina's Protective and Restorative Mechanisms on the Gut Microbiota with PPI, Using SHIME Technology.
    Duysburgh C; Verstrepen L; Broeck MVD; Righetto Z; Perez M
    Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vildagliptin increases butyrate-producing bacteria in the gut of diabetic rats.
    Zhang Q; Xiao X; Li M; Yu M; Ping F; Zheng J; Wang T; Wang X
    PLoS One; 2017; 12(10):e0184735. PubMed ID: 29036231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.